Portlock CS - Search Results

1

Mediastinal irradiation in combined modality therapy for Hodgkin's disease.

Dowling SW, Peschel RE, Portlock CS, Kramer C, Farber LR, Knowlton AH. Dowling SW, et al. Among authors: portlock cs. Int J Radiat Oncol Biol Phys. 1990 Sep;19(3):543-6. doi: 10.1016/0360-3016(90)90479-4. Int J Radiat Oncol Biol Phys. 1990. PMID: 2211202

2

Stage I and II subdiaphragmatic Hodgkin's disease.

Mai DH, Peschel RE, Portlock C, Knowlton A, Farber L. Mai DH, et al. Cancer. 1991 Oct 1;68(7):1476-81. doi: 10.1002/1097-0142(19911001)68:7<1476::aid-cncr2820680703>3.0.co;2-b. Cancer. 1991. PMID: 1893346

3

High-dose pulse chlorambucil in advanced, low-grade non-Hodgkin's lymphoma.

Portlock CS, Fischer DS, Cadman E, Lundberg WB, Levy A, Bobrow S, Bertino JR, Farber L. Portlock CS, et al. Cancer Treat Rep. 1987 Nov;71(11):1029-31. Cancer Treat Rep. 1987. PMID: 3677110

4

Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.

Koletsky AJ, Bertino JR, Farber LR, Prosnitz LR, Kapp DS, Fischer D, Portlock CS. Koletsky AJ, et al. Among authors: portlock cs. J Clin Oncol. 1986 Mar;4(3):311-7. doi: 10.1200/JCO.1986.4.3.311. J Clin Oncol. 1986. PMID: 3950674

5

Prognostic indicators in diffuse large-cell (histiocytic) lymphoma.

Todd MB, Portlock CS, Farber LR, Holford TR, Bertino JR. Todd MB, et al. Among authors: portlock cs. Int J Radiat Oncol Biol Phys. 1986 Apr;12(4):593-601. doi: 10.1016/0360-3016(86)90068-4. Int J Radiat Oncol Biol Phys. 1986. PMID: 2422144

6

Second Neoplasms in Patients With Hodgkin's Disease Following Combined Modality Therapy-The Yale Experience.

Koletsky AJ, Bertino JR, Farber LR, Prosnitz LR, Kapp DS, Fischer D, Portlock CS. Koletsky AJ, et al. Among authors: portlock cs. J Clin Oncol. 1986 May;4(5):817. doi: 10.1200/JCO.1986.4.5.817. J Clin Oncol. 1986. PMID: 28423288

7

High-dose cisplatin plus dacarbazine in the treatment of metastatic melanoma.

Murren JR, DeRosa W, Durivage HJ, Davis C, Makuch R, Portlock CS. Murren JR, et al. Among authors: portlock cs. Cancer. 1991 Mar 15;67(6):1514-7. doi: 10.1002/1097-0142(19910315)67:6<1514::aid-cncr2820670609>3.0.co;2-q. Cancer. 1991. PMID: 2001539 Clinical Trial.

8

T-cell rich B-cell lymphoma: clinical distinctiveness and response to treatment in 45 patients.

Ripp JA, Loiue DC, Chan W, Nawaz H, Portlock CS. Ripp JA, et al. Among authors: portlock cs. Leuk Lymphoma. 2002 Aug;43(8):1573-80. doi: 10.1080/1042819021000002893. Leuk Lymphoma. 2002. PMID: 12400599

9

Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent.

Teckie S, Qi S, Lovie S, Navarrett S, Hsu M, Noy A, Portlock C, Yahalom J. Teckie S, et al. Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):130-7. doi: 10.1016/j.ijrobp.2015.01.040. Int J Radiat Oncol Biol Phys. 2015. PMID: 25863760

10

Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease.

Hirsch A, Vander Els N, Straus DJ, Gomez EG, Leung D, Portlock CS, Yahalom J. Hirsch A, et al. Among authors: portlock cs. J Clin Oncol. 1996 Apr;14(4):1297-305. doi: 10.1200/JCO.1996.14.4.1297. J Clin Oncol. 1996. PMID: 8648387 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters